NOMAD POWER SOLUTIONS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $5.03 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2025-03-24
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $0.50.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2013-03-31 was $0.00.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $5.03.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2021 was $0.96.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2018 was $0.15.
- NOMAD POWER SOLUTIONS, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2023-12-31 | $5.03 10-K · filed 2025-03-24 | |||
| 2023-09-30 | $5.03 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | $5.03 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | $0.50 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $0.96 10-K · filed 2023-03-29 | |||
| 2021-09-30 | $0.96 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | $0.81 10-Q · filed 2021-08-10 | |||
| 2018-12-31 | $0.15 10-K · filed 2020-03-25 | |||
| 2013-12-31 | $0.00 10-K · filed 2014-03-21 | |||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-07 | |||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-05 | |||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 | |||
| 2012-12-31 | $0.33 10-K · filed 2014-03-21 | |||
| 2012-09-30 | $0.33 10-Q · filed 2012-11-13 | |||
| 2012-06-30 | $0.33 10-Q · filed 2012-08-10 | |||
| 2011-12-31 | $0.33 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |